
DepoCyt® (cytarabine liposome injection) is indicated for the intrathecal treatment of lymphomatous meningitis. DepoCyt is a cytotoxic anticancer drug and, as with other potentially …
DEPOCYT 50mg/5ml vial(cytarabine 阿糖胞苷脂质体注射液)
FDA正式批准了阿糖胞苷注射剂 (cytarabine liposome injection,DepoCyt),用于治疗一种致命性的淋巴瘤综合征——肿瘤性脑膜炎。 此前,DepoCyt获得了FDA的快速批准资格。 FDA批准 …
DepoCyt® (cytarabine liposome injection) is a sustained-release formulation of the active ingredient cytarabine designed for direct administration into the cerebrospinal fluid (CSF). …
DepoCyt: Package Insert / Prescribing Information - Drugs.com
DepoCyt is indicated for the intrathecal treatment of lymphomatous meningitis. (1) Initiate dexamethasone 4 mg twice a day either by mouth or intravenously for 5 days beginning on the …
DepoCyt: Indications, Side Effects, Warnings - Drugs.com
2024年3月10日 · Dexamethasone will be given before DepoCyt (cytarabine (liposomal)) to lower side effects. It is used to treat a type of cancer in the brain fluid. What do I need to tell my …
DEPOCYT-美国FDA药品数据库-药物在线
商品名:depocyt,活性成分:cytarabine,申请号:021041,申请人:pacira pharms inc
DepoCyt is available in 5 mL, ready-to-use, single-use formulated as a sterile, non-pyrogenic, white to 0.9% w/v in Water for Injection. DepoCyt is at a concentration of 10 mg/mL, and is...
DepoCyt (Cytarabine Liposome Injection): Side Effects, Uses ... - RxList
2021年12月13日 · DepoCyt® (cytarabine liposome injection) is a sterile, injectable suspension of the antimetabolite cytarabine, encapsulated into multivesicular lipid -based particles. …
脂质体阿糖胞苷 (DepoCyte) 用于治疗伊马替尼治疗期间发生的 …
脂质体阿糖胞苷 (DepoCyte) 用于治疗伊马替尼治疗期间发生的 CML 髓样 CNS 复发。 慢性粒细胞白血病 (CML) 中的中枢神经系统 (CNS) 复发很少见,如果有记录,通常会在淋巴母细胞转化 …
DepoCyte is to be administered by slow injection over a period of 1-5 minutes directly into the cerebrospinal fluid (CSF) via either an intraventricular reservoir or by direct injection into the …
- 某些结果已被删除